Will the CSL share price reach $400 in 2020?

The CSL Limited (ASX:CSL) share price has already surged beyond $300, can it reach $400 by the end of 2020?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is the CSL Limited (ASX: CSL) share price going to reach $400 in 2020?

It's definitely possible. Over the past year the CSL share price has gone up by 78% over the past year. Reaching a share price of $400 would only take a rise of 18.9% over the rest of this year.

Investors have been searching for growth in an investment world where most other ASX businesses are not going anywhere. The profit of a share like Telstra Corporation Ltd (ASX: TLS) is going backwards. The profit of National Australia Bank Ltd (ASX: NAB) is essentially flat.

CSL keeps delivering growth result after result, and market buying is making sure that CSL remains a good market performer. In the recent half-year report CSL announced constant current net profit growth of 11% to US$1.25 billion. FY20 net profit is expected to be in the range of US$2.11 billion to US$2.17 billion which would be growth of 10% to 13% over FY19.

It's impressive how CSL keeps going profit, but a lot of the share price rise is down to the healthcare giant becoming more expensive, rather than its profit growth keeping up with investor hype. Even with more growth expected in FY21, CSL is now trading at 40x FY21's estimated earnings.

If you think about it in PEG ratio terms, the price/earnings ratio compared to the growth rate, CSL looks expensive. A PEG ratio of 1 or less is good value, but CSL's PEG ratio is much higher than that.

Growth is an important factor in valuation. Buying volumes of shares is a factor in share price movements. But the p/e ratio of a share can't just keep going higher and higher forever. We've seen other highly-priced growth shares like Altium Limited (ASX: ALU) and WiseTech Global Ltd (ASX: WTC) fall back because the growth expectations were too high.  

a woman

Foolish takeaway

CSL is probably the highest-quality company within the ASX20, but it doesn't strike me as good value now. If the COVID-19 keeps going and turns into a global problem, maybe it will be called the global coronavirus/COVID crisis (GCC), then I think it will be hard for CSL to reach $400 this year.

There will be a time when the CSL share price dips, which then could be the right time to buy, but not today in my opinion. 

Tristan Harrison owns shares of Altium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of Altium, National Australia Bank Limited, and WiseTech Global. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »

Rising arrows and a 3D chart, indicating a rising share price.
Growth Shares

2 strong Australian stocks to buy now with $8,000

These businesses have a lot of long-term potential.

Read more »